Rebanta Meditech India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 7.00 M
- Revenue Growth %
- Profit Growth 87.02%
- Ebitda 87.02%
- Net Worth -72.61%
- Total Assets -86.60%
About Rebanta Meditech India
Rebanta Meditech India Private Limited (RMIPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 June 2016 (Eight years and seven months 26 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹7.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Jyoti Dhamdhere and Shailendra Dhamdhere serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999MH2016PTC282209
-
Company No.
282209
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Jun 2016
-
Date of AGM
28 Jun 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Rebanta Meditech India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jyoti Dhamdhere
|
Director | 31-May-2023 | Current |
|
Shailendra Dhamdhere
|
Director | 31-May-2023 | Current |
Financial Performance of Rebanta Meditech India.
Rebanta Meditech India Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 87.02% increase in profit. The company's net worth observed a substantial decline by a decrease of 72.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rebanta Meditech India?
In 2023, Rebanta Meditech India had a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Talentco Hr Services LlpJyoti Dhamdhere is a mutual person
Charges (Loans)
₹0
₹7.00 M
Charges Breakdown by Lending Institutions
- Others : 0.35 Cr
- Yes Bank Limited : 0.35 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Dec 2019 | Yes Bank Limited | ₹3.50 M | Satisfied |
| 05 Oct 2016 | Others | ₹3.50 M | Satisfied |
How Many Employees Work at Rebanta Meditech India?
Unlock and access historical data on people associated with Rebanta Meditech India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rebanta Meditech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rebanta Meditech India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
